Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pharmacist-led education about stopping non-cancer medicines for palliative cancer patients

Official title: Attitudes Towards Deprescribing of Non-oncologic Medication in Cancer Pacient and the Impact of an Educational Intervention by a Clinical Pharmacist

Run by Iuliu Hatieganu University of Medicine and Pharmacy · NCT06771999 · Data updated 2026-11-12

This project will see if a brochure and short video from a clinical pharmacist change how Romanian palliative cancer patients feel about stopping non-cancer medications.

More Palliative Care trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorIuliu Hatieganu University of Medicine and Pharmacy
Academic / other
Locations1 site (Baia Mare, Maramureş)
StatusRecruiting
StartedJanuary 13, 2025
Main results expectedApril 30, 2026
Study endsApril 30, 2027
Registry record updatedFebruary 13, 2026
Trial IDNCT06771999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with cancer receiving palliative treatment who are Romanian-speaking, have ECOG performance status 1–2, and no cognitive impairment are ideal candidates.

Probably not a fit

Patients receiving curative-intent cancer treatment, those with ECOG 3–4 or cognitive impairment, or those unable to read or understand Romanian are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Palliative cancer patients who meet inclusion criteria complete validated Romanian questionnaires about attitudes to deprescribing (rPATD) and health literacy (HLS-EU-Q16). Participants then receive an educational brochure and watch a short video delivered by a clinical pharmacist about medication risks, benefits, and patient involvement in decisions. The rPATD questionnaire is repeated at the next treatment visit to measure changes in willingness and beliefs about stopping non-oncologic drugs. The study is conducted at Constantin Opris Emergency County Hospital in Baia Mare and excludes patients with cognitive impairment or poor performance status (ECOG 3-4).

Why it matters

Potential benefit: If successful, the intervention could increase patients' knowledge and willingness to discuss stopping unnecessary medications, potentially reducing medication-related harms.

How similar studies have gone: Related pharmacist-led education and deprescribing interventions have improved medication knowledge and willingness to stop medicines in older adult populations, but evidence specifically in palliative cancer patients—particularly in Romania—is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* cancer patients in palliative treatment
* ECOG 1-2

Exclusion Criteria:

* cancer patients in curative treatment
* ECOG 3-4
* cognitive impairment

Where it's running

  • Constantin Opris Emergency County Hospital
    Baia Mare, Maramureş, Romania
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.